Life Science Company News

Reset
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Can-Fite BioPharma Ltd

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

Read more ››
By: GlobeNewswire - 04 Dec 2024

The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Multiple Myeloma Research Foundation, Inc.

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  EyePoint Pharmaceuticals, Inc.

Health Care Resource Centers Debuts Refreshed Logo and Brand Identity as a BayMark Health Provider

Read more ››
By: GlobeNewswire - 04 Dec 2024

Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Atea Pharmaceuticals, Inc.

Hop Valley Brewing Co. and Portland Trail Blazers Partner to Launch New Hop Box Bar at Moda Center

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Tilray Inc.

Coloplast divests core Skin Care product portfolio

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Coloplast A/S

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Plus Therapeutics, Inc.

Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Quipt Home Medical, Corp.

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Theratechnologies Inc.

Relmada Therapeutics Reports That Data Monitoring Committee (DMC) Assessment Indicates That the Phase 3 Reliance II Trial is Futile at its Interim Analysis and is Unlikely to Meet the Primary Efficacy Endpoint with Statistical Significance

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Relmada Therapeutics, Inc.

Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy

Read more ››
By: GlobeNewswire - 04 Dec 2024

Augmedix Achieves Oracle Validation with Industry Healthcare Expertise for Delivering Proven, Repeatable Integration

Read more ››
By: GlobeNewswire - 04 Dec 2024

Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Dewpoint Therapeutics | Dewpoint Therapeutics GmbH

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference

Read more ››
By: GlobeNewswire - 04 Dec 2024

Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Cidara Therapeutics, Inc.

Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Daré Bioscience, Inc.

X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  X4 Pharmaceuticals, Inc.

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

Read more ››
By: GlobeNewswire - 04 Dec 2024
Related companies:  Windtree Therapeutics, Inc.
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »